Novasep provides an extensive range of contract development & manufacturing (CDMO) services to the pharmaceutical industry for both Small Molecule APIs and Biopharmaceuticals. With 1,300 employees, Novasep is established in Europe, Asia and North America and is constantly expanding its presence to better serve its customers. We aim to be a highly respected, top tier service provider through the passion of our people and the excellence of our processes.
Our CDMO services include:
APIs and HPAPIs
cGMP intermediates and starting materials
Viral vectors (AAV, ADV, Lentiviral vectors…)
Monoclonal antibodies and other recombinant proteins
Antibody drug conjugates (ADCs)
Fill & Finish for biologics
We offer a wide range of flexible development & commercial assets on cGMP multiple sites with an outstanding regulatory track record.
Novasep is a world leader in a number of technologies including industrial chromatography (batch and continuous), hazardous & cryogenic chemistry, high potency & cytotoxics, supported by an extensive toolbox of classical technologies.
Our ongoing investments in additional bio-facilities can also contribute to your project's success:
Senrise-IV: a new commercial manufacturing facility for viral vectors, in Novasep Seneffe, Belgium
Senefill: a new commercial facility for aseptic Fill&Finish operations in Novasep Seneffe, Belgium (filling of mAbs, viral vectors, plasmids and other biologics)
mAbulous: a new clinical manufacturing facility for mAbs and recombinant proteins, in Novasep Pompey, France, addressing both process transfer and cGMP production